Liberty Island Partially Reopens As Phase 4 Begins – CBS New York

Posted on by

Mayor Bill de Blasio Pays Tribute To CBS2 Reporter Nina KapurMayor Bill de Blasio began his daily briefing Tuesday by paying tribute to CBS2's Nina Kapur.

New York Weather: July 21 Tuesday Afternoon CBS2 Weather HeadlinesCBS2's Elise Finch has a look at the forecast.

Concern About Water Supply On Long IslandSuffolk County is telling residents to stop watering their lawns during early morning hours amid near-record usage levels.

Beachgoers Help Save Stranded Dolphin In New JerseyBeachgoers in Sandy Hook used a beach towel to help move the stranded mammal from the sand back into the water.

Food Delivery Drivers Targeted By Car Thieves On Long Island; Its Either A Bad Address Or The People Didnt Order FoodPolice warn thieves are stealing cars left running in the driveways of homes during food deliveries in Suffolk County. CBS2's Carolyn Gusoff reports.

Glitch Causes Delay In Federal Unemployment Checks, Leaving Many On Edge About MoneyIf you receive federal unemployment payments, in addition to state unemployment, you may have noticed your money wasnt in your account this week. CBS2's Natalie Duddridge reports.

Some Teachers Take Legal Action To Stop In-Person ClassesCoronavirus cases have been spiking in dozens of states. Now some teachers are taking legal action to stop in-person classes from starting. Chris Martinez reports.

MVCs Wayne Licensing Center Temporarily Closed After Employee Tests Positive For COVID-19The New Jersey Motor Vehicle Commissions Wayne Licensing Center is closed for the week after officials say an employee tested positive for COVID-19.

Gunman Suspected Of Ambushing Judges Family May Have Also Been Targeting Another Top Judge, Authorities SayNew details are emerging about the gunman suspected of ambushing federal Judge Esther Salas family inside their New Jersey home. CBS2's John Dias reports.

Large Sinkhole Forms On Upper East Side EsplanadeA large sinkhole has formed on the walkway next to the East River. CBS2's Dan Rice reports.

Mayor Bill de Blasio Holds Daily BriefingMayor Bill de Blasio began his daily briefing by paying tribute to CBS2's Nina Kapur, who passed away over the weekend. He then discussed food insecurity, concerns about paying rent and settling rent disputes, and more.

Mayor Bill de Blasio Pays Tribute To Nina KapurMayor Bill de Blasio began his daily briefing by paying tribute to CBS2 reporter Nina Kapur, who passed away this weekend.

Author DW Gibson On Book "14 Miles: Building The Border Wall"The Simon & Schuster author talks with CBS Local's DJ Sixsmith about his new book on the border wall, the people he met around the border in California and the future of border security.

Nicki Minaj Announces PregnancyThe Queens native shared the news on her Instagram.

Commuter Alert: Truck Fire On Gowanus ExpresswayChopper 2 is over the scene of a truck fire that's causing delays on the Gowanus Expressway in Brooklyn.

Woman Suspected In Times Square RobberyPolice are searching for a woman they say robbed another woman back on 4th of July in Times Square.

Massive Fire On South Jersey FarmA massive fire has been burning for hours on a farm in Salem County, New Jersey.

Woman's Body Pulled From East RiverPolice pulled a woman's body from the East River just before 11 p.m. Monday.

2 Killed In Fiery Bronx CrashTwo people are dead after police say a speeding car hit three other vehicles overnight in the Bronx.

Learning More About Gunman Accused Of Ambushing Judge's FamilyThe investigation continues this morning into the deadly shooting at the home of a federal judge in New Jersey. Her son was killed and her husband critically wounded, and now we're learning more about the gunman. CBS2's John Dias reports from the scene of the tragedy.

New York Weather: Another Hot OneCBS2's Elise Finch has the latest weather forecast.

Remembering CBS2's Nina KapurThe CBS2 family is mourning the loss of reporter Nina Kapur, who was killed Saturday in a moped accident in New York City. She is being remembered as an amazing storyteller. Here's CBS2's Lisa Rozner with Nina's story.

New York Weather: Heat Wave To Continue TuesdayCBS2's Lonnie Quinn says we'll get a slight break with the humidity on Tuesday, but temperatures will still be in the 90s. Here's your 11 p.m. forecast.

Serious Progress Made In Development Of Coronavirus VaccineThere is encouraging news in the race to develop a vaccine for the coronavirus. One of the top contenders is showing real results. CBS2's Dick Brennan reports

More:

Liberty Island Partially Reopens As Phase 4 Begins - CBS New York

Getting There: Barker interchange project set to start, but WSDOT revenue woes may jeopardize related Liberty Lake work – The Spokesman-Review

Posted on by

The first in a series of projects aimed at decreasing congestion and improving safety in rapidly growing Spokane Valley and Liberty Lake was supposed to get going Monday. But the start date has been pushed back a week, because the contractor wasnt quite ready.

If thats the last of the delays on the three projects planned to take place over the next two years between Barker to Harvard roads along Interstate 90, officials at the Washington State Department of Transportation in Liberty Lake and in Spokane Valley will be relieved.

Last month, the state released its legally mandated transportation revenue forecast, and the outlook it depicted wasnt exactly sunny.

Among its key conclusions: transportation revenues for WSDOTs current two-year planning period, which started last year and ends next year, will drop sharply by about $482 million, or almost 8%. That expected drop is attributed to impacts of Initiative 976, which will reduce the cost of car tabs and also the size of WSDOTs coffers, and of COVID-19, which led to fewer cars on the road and less revenue for the department from gas taxes.

The reports authors also anticipate a slow recovery from the COVID-19 shutdowns that will lead to a 3.5% drop in revenue over the next 10 years.

So what does that mean for not only the Barker- to-Harvard project, but also the North Spokane Corridor and all the other planned and potential transportation work in Eastern Washington?

We just dont know, Beth Bousley, a spokeswoman for WSDOTs Eastern Region, said this week.

The answer, she said, will have to be hashed out in Olympia, where Gov. Jay Inslee and state legislators will have big conversations about what, if any, projects will be delayed or axed altogether.

In the meantime, though, Were still moving forward as if nothing were to happen, said Tom Brasch, the WSDOT project engineer overseeing construction in the Barker-to-Harvard corridor.

If nothing were to happen, crews would replace the traffic signals at the top of the Barker interchange ramps with a roundabout this summer, widen the Harvard Road overpass and improve the Harvard westbound on-ramps this fall, and next summer construct a new Henry Road connection over I-90 from Mission Avenue on the north to Country Vista Drive to the south.

The almost $4.5 million Barker piece seems certain to happen. When it gets underway, Brasch said crews will work around the clock six days a week to get much of it done and out of the way by Labor Day.

That fast timeline was set to ensure the project didnt disrupt the Central Valley School Districts nearby bus barn on Cataldo Avenue just when schools are slated for what is now a highly uncertain start.

But the quick pace of construction will mean some major disruptions for drivers over two 10-day periods when first the north and then the south intersections of Barker and the interstate ramps are closed completely. During those periods, drivers also wont be able to cross the interstate on Barker, meaning they will be detoured all the way to Flora Road to the west and Harvard Road to the east to travel north or south.

In mid-September, when the Barker project should be mostly complete, WSDOTs focus will shift, if nothing changes, to Liberty Lake.

First up on the schedule is the $6 million Harvard Road interchange project, which is slated to go to bid this week.

There, Brasch said, drivers heading north from Liberty Lake currently have to merge from two lanes to one before crossing I-90, which really bogs down traffic in the area, especially during peak times. To improve the flow of traffic, the road will be widened to two northbound lanes over I-90.

The westbound on-ramp will also be improved. During construction, Brasch said, the plan is to keep the majority of the roads open.

The last and largest piece of the puzzle is the new Henry Road extension and overpass, which is supposed to begin next summer and end a year later, in mid-2022.

While Brasch said so far as we know, nothing is stopping the project from moving forward as planned, Katy Allen, city administrator of Liberty Lake, is less sure that the Harvard and Henry projects in her city will happen on the existing timeline.

Ill be honest with you, she said last week, construction funding for these projects is up in the air.

That uncertainty has Allen concerned. She said creating a new north-south link via Henry Road is crucial for the growing city, which literally goes into meltdown and gridlock when traffic is impeded on the stretch of I-90 that splits Liberty Lakes north and south sections. Currently, Harvard Road is the only way across and it sees about 22,000 average daily trips.

With a new middle school opened last fall and a new high school slated to open at the start of the 2021 school year, Allen said the need for the Henry Road connection is only more urgent.

What Henry Road provides is redundancy, so we can get some circulation going, Allen said. You just open a lot of options when you put in this link.

To help get the $15 million project funded, Allen said the city of Liberty Lake is contributing $6 million of its own money for design and right-of-way work, while Spokane County pitches in another $1.5 million or so. The $8.5 million in construction costs will come from the states Connection Washington program.

While she acknowledges its still up to WSDOT whether the work moves forward, Allen said that because we have skin in the game, if theres funding thats going to be cut back, we hope that the fact that were bringing money to the table will help give us an advantage.

Our strategy, she continued, is to stay the course and keep moving and be ready when we get the nod for the funding. But I guarantee you this, if we arent ready, we wont get the nod. So were doing everything we can to stay funded and on budget.

We just want to be ready to go.

Crews will be pouring the concrete deck for a new overpass at the Medical Lake/I-90 interchange this week. That means eastbound lanes of I-90 will be closed Monday at 9 p.m. until Tuesday at 5 a.m. Westbound lanes will close Wednesday from 9 p.m. to 5 a.m. Traffic will be routed off the interstate, up the exit ramps and back onto I-90.

Ted McDermott can be reached at (509) 459-5405 or at tedm@spokesman.com

The rest is here:

Getting There: Barker interchange project set to start, but WSDOT revenue woes may jeopardize related Liberty Lake work - The Spokesman-Review

John Bolton Gambles That Constitution Will Save Profits on Book That Was Embarrassing to the President – Law & Crime

Posted on by

Former Ambassador and National Security Advisor John Bolton is hoping the First Amendment saves him from claims by the government that he violated his own nondisclosure agreements and should therefore be penalized for publishing his recent memoir about President Donald Trumps White House.

A 44-page motion to dismiss all claims against Bolton, filed by his attorneys late Thursday in Federal District Court in Washington, D.C., leans heavily of the right to speak freely about matters of political importance in its opening paragraphs and subsequent arguments.

Speech on a politically important and controversial topic is the essence of First Amendment expression, the motion begins. No form of speech is entitled to greater constitutional protection.

Boltons motion comes after a federal district court judge ruled in late June that Bolton could publish his book as a matter of First Amendment law but that Bolton had gambled with the national security of the United States, exposed his country to harm, and furthermore exposed himself to civil (and potentially criminal) liability. Bolton, with his book now for sale worldwide, argues he should face no liability at all. (Given the federal judges June rebuke of Bolton, which called Boltons tactics a gamble, some arent so sure these arguments will work.) Still, Boltons motion takes aim at the governments use of nondisclosure agreements to prevent officials from speaking about how public business is conducted.

When the Government erects a scheme designed to foreclose that speech even before it is uttered by imposing a prior restraint upon the communication of news and commentary on current events, it must shoulder a heavy burden of showing justification for the imposition of such a restraint, the document goes on to say (internal citations and punctuation omitted). And it has been settled since the Early Republic that the Government cannot escape First Amendment scrutiny by switching to the tactic of punishing core political speech after the fact.

That line is aimed at government claims that Bolton should be forced to forego royalties or even be punished criminally for publishing his book, The Room Where It Happened: A White House Memoir.

[A] law inflicting penalties on printed publications, would have a similar effect with a law authorizing a previous restraint on them, Boltons motion then says, quoting James Madison, the author of the First Amendment. It would seem a mockery to say, that no law should be passed, preventing publications from being made, but that laws might be passed for punishing them in case they should be made.

The Bolton motion invites the D.C. District Court to not forget these bedrock constitutional principles in evaluating the Governments attempt in this case to punish the Presidents former National Security Advisor, Defendant John R. Bolton, for publishing speech that is embarrassing to the President.

The Bolton motion invoked previous arguments that a nearly four-month pre-publication government review of Boltons book ferreted out classified information, that Bolton was free to publish, and that the Trump White House continued to assert that classified information existed in the book merely to prevent it from being published. To that end, Boltons motion asserts that neither of his own nondisclosure agreements imposes on a former government employee any obligationnone at allto submit for prepublication review:

The Governments claims are all foreclosed by the text of the very contractual documents upon which they purport to be based, since those contracts simply cannot reasonably be interpreted as imposing the contractual duty that the Government claims Ambassador Bolton breached: the duty to submit to prepublication review, and await written authorization before publishing, a book that he had no reason whatsoever to believe contained any classified material. And even if those contracts were susceptible to an interpretation imposing such a requirementin effect, a blanket prior restraint of virtually any speech by former government employeesthat requirement would be flatly contrary to the First Amendment. The Court thus labors under the solemn constitutional duty to avoid interpreting the contracts, if at all possible, as imposing such a blanket prior restraintand if such an interpretation is not possible, the even more solemn duty to invalidate that plainly unconstitutional requirement.

The motion concludes that even if the governments interpretations of Bolstons so-called Sensitive Compartmented Information Nondisclosure Agreement (SCI NDA) are true, they do not stand in the face of the First Amendment.

READ Boltons arguments in the document below:

John Bolton Motion to Dismiss by Law&Crime on Scribd

[photo by Win McNamee/Getty Images]

Have a tip we should know? [emailprotected]

Excerpt from:

John Bolton Gambles That Constitution Will Save Profits on Book That Was Embarrassing to the President - Law & Crime

My View: In Provincetown, strange views of the First Amendment – Wicked Local Provincetown

Posted on by

I was tagged in these pages last week as mystery man the person Town Moderator Mary-Jo Avellar reported to the police for handing out fliers criticizing her as I stood on Commercial Street outside her workplace. Im not really a mystery. Ive been a part-time resident and taxpayer here for 20 years.

After Ms. Avellar took my picture, her Finance Committee appointee Mark Hatch posted it on Facebook in an effort to divine my identity. It wasnt a coincidence that Hatch, who chairs that committee, anointed himself Avellars private investigator.

Under the town charter, Avellar is primarily responsible for reviewing recent allegations thatHatch authored social media posts that were misogynistic, anti-Semitic, and otherwise degrading toward immigrants and participants in Black Lives Matter protests. But like most of Provincetowns elected leaders, shes brushed off Hatchs pattern of intemperate online hate speech.

Instead of taking appropriate action, she foreshadowed the later comments of our witless President when she recently told the Banner, Even the Ku Klux Klan . . . are entitled to free speech. Yet no one has a constitutional right to serve on a town committee, much less chair it. Even House Republicans found enough guts to kick Rep. Steve King (R-Iowa) off his committees for the bigotry he voiced.

In a true perversion of the First Amendment, several of Hatchs Facebook followers seem to think it was bad taste or even illegal to protest against a public official on a public street in front ofthat person'sworkplace. Heres what I think: Its bad taste not to mention, ignorant for the Town Moderator to invoke the Ku Klux Klan as an excuse for protecting the alleged hate speech of her own appointee. The Klan is a terrorist organization primarily known for beating and murdering African-Americans, as well as Jews, Catholics, immigrants, and their allies.

I took this step because Avellars outrageous excuse required an outraged response. Many people here today are immigrants, as were the ancestors of many Provincetown families. At least half the towns population is female. Our neighbors include Jews and people of color. We deserve better from the Town Moderator and the Finance Committee.

That committees Code of Conduct states, Remember that you represent the entire community at all times not just while sitting behind a dais. If Provincetown is supposed to be a loving, welcoming community, committee chairs shouldnt spew hate online, and a top elected official cant hide behind the KKK as a reason for refusing to investigate credible allegations that this Code of Conduct provision was violated.

The Town Moderator has already prejudged this matter, so it would be inappropriate for her to act on it. But under Chapter 3, Section 5 of the town charter, the Select Board may investigate and impose sanctions for the alleged misconduct of any member of a town board, commission, or committee. Theres been a formal complaint filed. Its time for the Select Board to step up and act.

Its also well past time the Town Moderator was reminded that her job, by definition, is to create order out of chaos not to keep sowing greater chaos, either among the Towns residents or leaders. If some confidantes would have the courage to tell her that, maybe shed take the message to heart.

Go here to see the original:

My View: In Provincetown, strange views of the First Amendment - Wicked Local Provincetown

Second Circuit Wrecks All Sorts Of First Amendment Protections To Keep Lawsuit Against Joy Reid Alive – Techdirt

Posted on by

from the what-public-discourse dept

The Second Circuit just issued an ugly decision in a defamation lawsuit against Joy Reid. It not only revived the case against her, but it greased the skids for many more defamation cases to be brought in federal court, including plenty even less meritorious.

The case, La Liberte v. Reid, involves two of Reid's social media posts from 2018. The first was from June 29:

At some point during the Council Meeting, La Liberte was photographed interacting with a fourteen-year-old teenager who appears to be (and is) Hispanic (the "Photograph"). The Photograph showed La Liberte with her mouth open and her hand at her throat in a gagging gesture. On June 28th, a social media activist named Alan Vargas tweeted the Photograph along with the following caption: "'You are going to be the first deported' [and] 'dirty Mexican' [w]ere some of the things they yelled they yelled [sic] at this 14 year old boy. He was defending immigrants at a rally and was shouted down. Spread this far and wide this woman needs to be put on blast." The Photograph went viral. The next day, Joy Reid, a personality on the MSNBC cable station, retweeted (i.e., shared) the Vargas tweet to her approximately 1.24 million followers. (La Liberte is not alleging defamation by Reid as to that communication.) Later that same day (June 29), Reid posted the Photograph on her Instagram with the following caption: "He showed up to a rally to defend immigrants . . . . She showed up too, in her MAGA hat, and screamed, 'You are going to be the first deported' . . . 'dirty Mexican!' He is 14 years old. She is an adult. Make the picture black and white and it could be the 1950s and the desegregation of a school. Hate is real, yall. It hasnt even really gone away." [p.6-7]

The second was from July 1:

Two days later (July 1), Reid published another post about La Liberte, this time on Instagram and Facebook. This post juxtaposed the Photograph of La Liberte with the 1957 photograph showing one of the Little Rock Nine walking past a screaming white woman. Reid added the following caption: "It was inevitable that this [juxtaposition] would be made. It's also easy to look at old black and white photos and think: I can't believe that person screaming at a child, with their face twisted in rage, is real. By [sic] every one of them were. History sometimes repeats. And it is full of rage. Hat tip to @joseiswriting. #regram #history #chooselove" [p. 7-8]

Subsequently, further media coverage revealed that the plaintiff had not been the source of the cited racist comments. [p. 7] On July 2 the plaintiff contacted Reid to ask that she delete the posts and apologize, which Reid did later that day. [p. 8]. Despite her doing so, the plaintiff sued anyway, but the district court in EDNY then dismissed it.

The Second Circuit has now stepped in to revive the case, and in doing so opened the door not only to this troublingly weak case but plenty of others even weaker.

There are a number of issues with the decision:

Section 230 became an issue because Reid had raised it as a defense for her June 29 posting of the picture on Instagram with her caption (although not her July 1 post on Instagram and Facebook). The district court rejected that defense, and the Second Circuit agreed with that rejection. But whereas it mattered less in the district court because it had found other reasons to dismiss the case against Reid, because the Second Circuit kept the case alive, it doing so also on Section 230 grounds raises more concerns (plus, it is an appeals court, so its decision will reverberate more into the future).

In denying her the statute's protection the court did get the basic rules right: only the party that created the offending expression can be held liable for it. Furthermore, citing earlier Circuit precedent, "a defendant will not be considered to have developed third-party content unless the defendant directly and 'materially' contributed to what made the content itself 'unlawful.'" [p. 22]. But in denying her the protection it applied these rules in a way that may expose myriad other social media posters - and even platforms themselves - to litigation in the future, and in a way that Section 230 should really forestall.

Reid was ostensibly only being sued for the commentary that she added to her re-posts of the original picture, and not the photographer's original tweet. Had it been the latter, Section 230 would have more clearly applied. Asserting it for her own speech is an aggressive argument, but not a ridiculous one. It's also not one that the court dismissed out of hand. As that prior precedent made clear, liability for speech hinges on who imbued the speech with its allegedly wrongful quality. Reid argued that it wasn't her: The original post had been of a picture of the plaintiff seemingly shouting threateningly at a Latino boy, and included a caption indicating that this picture was captured at an event where racist invective was shouted at him. Thus it was reasonable to take the original post as the statement that La Liberte was one of the people doing that shouting. Unfortunately that statement turned out to be wrong, but Reid repeating that statement in her own words was not what introduced the wrongfulness. Therefore she was not actually the "information content provider" with respect to this message, and Section 230 should have applied.

The trouble is, in the court's view, she had been the one to imbue the message with its wrongful quality. What might have made this case a close call was that the original post had only included an unspecific "they" in reference to the shouters, whereas Reid had attributed it to the plaintiff by name. However that attribution had already been made in the original post not by her name, true, but by her picture. Thus Reid did not introduce anything new to the overall expression. Indeed, that she believed, albeit erroneously, that the plaintiff had screamed the invective at the boy was because that was the message the original post had conveyed. It may have been an erroneous message, but she was not the one who originated it.

The problem with now finding her the "information content provider" in this situation is that it reads into Section 230 a duty of care that does not exist in the statutory language, requiring people who share others' expression to make some sort of investigation into the veracity of that expression. While it might be good if people did we certainly would like for people sharing things on social media to be careful about what they were sharing Section 230 exists because it is hard to get intermediation of expression right, and we risk choking off speech if we make it legally risky to get wrong. (See what happened to Reid, where even if she had been wrong about the significance of the underlying tweet, it was a reasonable error to make.)

Worse, not only would it chill social media sharing, but this decision is unlikely to stay tightly cabined to that sort of intermediation of others' expression. If it were the rule that you had to vet the expression you allowed to be shared before you could be safe from sharing other people's expression, then Section 230 could almost never apply and *everyone* would be vulnerable to being sued over the expression they intermediate, since no matter how much care they took since they'd still have to defend those efforts in court. Such a rule would represent a profound shift in how Section 230 works, which up to now has not been conditional. Twenty-plus years of jurisprudence has made clear that Section 230 protection is not contingent on the intermediary vetting the expression produced by third parties that it helps share, and this decision undermines that clarity. And not just for social media users, but the platforms they use as well.

Ultimately, if Section 230 can apply to individuals sharing others' social media posts (prior precedent supports that conclusion, and this court accepted it as well [see footnote 8]) and if it can apply to original, summarizing content (as this court also accepted), then there's no principled reason it should not have applied here.

Limited-purpose public figures

Denying Section 230 protection is only the tip of the iceberg. Not only does it make people who share on social media vulnerable to being sued, but other aspects of the decision make it more likely that it is litigation they will lose.

The court's refusal to find that the plaintiff was a limited purpose public figure is one of these aspects. Because open discourse about matters of public concern is a value the First Amendment exists to protect, the Supreme Court has developed the concept of the "public figure" to help ensure that it is. A public figure is someone whose fame has so intertwined them in matters of public interest that they must plead "actual malice," a fairly exacting standard, on the part of a speaker in order to prevail on a claim that the speaker defamed them.

Here, no one argued that the plaintiff was a general purpose public figure. But there are also "limited-purpose public figures." These are people who are not inherently intertwined in matters of public interest but who may insert themselves in matters that are and thus become public figures within the context of that matter. In such cases they would also need to plead actual malice in any defamation lawsuit where there had been commentary about them in this context.

Reid argued that the plaintiff was a limited purpose public figure. In particular, she regularly appeared at council meetings about the immigration issue and had been visibly, and publicly, vocal on the subject. The court rejected the contention:

That is not nearly enough. [T]he district court did not take into account the requirement that a limited purpose public figure maintain "regular and continuing access to the media." One reason for imposing the actual malice burden on public figures and limited purpose public figures is that "[t]hey have media access enabling them to effectively defend their reputations in the public arena." We have therefore made "regular and continuing access to the media" an element in our four-part test for determining whether someone is a limited purpose public figure. [p. 24-25]

Per the court, "La Liberte plainly lacked such media access." [p. 25].

The earlier photograph, which showed her conversing, was in a Washington Post photo spread of attendees at an SB 54 protest. The article did not name La Liberte, let alone mention her views. The single caption described everyone depicted as [s]upporters and opponents of [SB 54] rally[ing] and debat[ing] outside Los Alamitos City Hall. Such incidental and anonymous treatment hardly bespeaks regular and continuing access to the media. [p. 25]

Furthermore:

Nor does La Libertes participation at city council meetings. La Liberte is said to have testif[ied] eight times around the state (Appellees Br. at 26 (citing App. at 102-05)); but Reid does not identify instances in which the media singled out La Libertes participation as newsworthy. Nor does speech, even a lot of it, make a citizen (or non-citizen) fair game for attack. Imposition of the actual malice requirement on people who speak out at government meetings would chill public participation in politics and community dialogue. [p. 26]

The problem with this analysis is that it better applies to why a person engaging in civic affairs does not become a full-fledged public figure, where every aspect of their life can be a matter of public interest. It misses the significance of why we have the limited purpose public figure doctrine in the first place, which is that in the context of a specific matter of public concern a person's behavior can become a matter of public interest. Here the plaintiff had concertedly inserted herself into a matter of public concern the policymaking surrounding immigration - on a "regular and continuing" and conspicuously public basis. The court's ruling puts that public behavior beyond the reach of effective public comment by treating it as if it were private and thus lowering the standard of what the plaintiff would have to plead to support a defamation claim.

State anti-SLAPP in federal court

The decision also reaches an unfortunate conclusion we've taken issue with before: disallowing state anti-SLAPP laws in cases that end up in federal court via diversity jurisdiction. It's a conclusion that seems to reflect dubious constitutional analysis, is bad policy, and in this case, conflicts with Ninth Circuit precedent.

As we explained before:

Diversity jurisdiction arises when the parties in the litigation are from separate states and the amount in controversy is more than $75,000 and the issue in dispute is solely a question of state law. Federal courts ordinarily can't hear cases that only involve state law, but because of the concern that it could be unfair for an out-of-state litigant to have to be heard in a foreign state court, diversity jurisdiction can allow a case that would have been heard in state court to be heard by the federal one for the area instead.

At the same time, we don't want it to be unfair for the other party to now have to litigate in federal court if being there means it would lose some of the protection of local state law. We also don't want litigants to be too eager to get into federal court if being there could confer an advantage they would not have had if the case were instead being heard in state court. These two policy goals underpin what is commonly known as the "Erie doctrine," named after a 1938 US Supreme Court case that is still followed today.

The first problem with the Second Circuit's decision is that it does not even *mention* the Erie doctrine instead it just dives right into a procedural rules' analysis. [p. 13]. The second problem is that its decision directly conflicts with Ninth Circuit precedent that applied Erie to find that California's anti-SLAPP law indeed applied in federal diversity occasions. In other words, the Second Circuit has just reached across the country and into the Ninth Circuit to snatch away the protection of a law that the Ninth Circuit already had assured Californians that they had.

The third problem is that it is bad policy because it would encourage forum-shopping, which is normally discouraged. As the Ninth Circuit articulated in that case, US Ex Rel. Newsham v. Lockheed Missiles & Space Co.:

[I]f the anti-SLAPP provisions are held not to apply in federal court, a litigant interested in bringing meritless SLAPP claims would have a significant incentive to shop for a federal forum. Conversely, a litigant otherwise entitled to the protections of the Anti-SLAPP statute would find considerable disadvantage in a federal proceeding.

The Second Circuit appeared indifferent to these concerns:

Finally, amici warn that refusal to apply the anti-SLAPP statute will encourage forum shopping and lead to an increased burden on federal courts in this Circuit. (Amici Br. at 11.) That may be so; but our answer to a legal question does not turn on our workload; and in any event, the incentive to forum-shop created by a circuit split can be fixed, though not here. [p. 16]

The concern about forum-shopping is not that it will overburden federal courts; the concern the is manifest unfairness to defendants that will arise when they suddenly lose the benefit of the the substantive protections for speech California gave them and upon which they may have depended on to speak because an out-of-state litigant was able haul them into federal court.

Mootness

It is also not clear why the Second Circuit even reached the anti-SLAPP question. If its public figure analysis was correct, the defense would be unlikely to be able to even use it, because by that logic the expression at issue would have failed to meet the anti-SLAPP law's requirement that it be about a matter of "public issue." Thus there was no need for this court to ever reach the anti-SLAPP question, and yet it chose to opine on it first, before even reaching the Section 230 and then the public figure discussions. But because after those latter two analyses there was no reason to reach the anti-SLAPP discussion, and it raises the question of whether at this point it was even a ripe enough issue for the court to have had appellate jurisdiction over. But even if it did, doctrines of judicial restraint should have precluded deciding the issue and creating a mess that speakers who thought they were protected will now have to contend with.

Filed Under: 2nd circuit, anti-slapp, defamation, joy reid, la liberte, public figure, retweets, section 230

More here:

Second Circuit Wrecks All Sorts Of First Amendment Protections To Keep Lawsuit Against Joy Reid Alive - Techdirt

Staff column: the Wide World of Politics, in Brighton – Brighton Standard-Blade

Posted on by

Im not old enough to have watched ABCs Wide World of Sports myself, but Ive heard tell. Apparently, there were all sorts of events televised on the program, from log rolling to arm wrestling to demolition derbies.

The Blades news headlines werent so different this past week. On Tuesday, Brighton City Council unanimously voted to opt out of Tri-County Health Departments mask mandate, joining other cities that could be on the more conservative end of the political spectrum. Eventually, that vote was nullified by Gov. Jared Polis statewide mandate.

However, city councils vote, its leadup and its aftermath were fascinating to observe. Some people see mask wearing as a simple act that helps ensure public health and safety. Others cite different scientific claims arguing the opposite. Then theres a whole other cohort that opposes the mandate because they dont like orders from Tri-Countys board, who Mayor Greg Mills called unelected bureaucrats. After council cast its vote, residents didnt hesitate to share those differing opinions with fierce passion.

The night thereafter, I saw another side of politics I hadnt previously: First Amendment auditing. At a city council finalist meet-and-greet, three YouTubers showed up to pose a series of questions to finalist Jane Shang. All the while, they live streamed the confrontation on YouTube. After the confrontation happened, I pulled these figures aside to ask them questions, which they also proceeded to live stream.

The next day, I learned a little more about their shtick. First Amendment auditors is a term loosely used to describe a community of YouTubers that tests the First Amendments limits. A person in that camp who I spoke with described another auditor as a constitutionalist, or in this instance, someone who acts out of an inerrant, superseding belief in rights granted by the U.S. Constitution.

These auditors live stream themselves in public, confronting police officers or public officials who they allege are corrupt. They keep at it until, many times, authorities see no other choice but to arrest them. When that YouTuber is arrested, though, their supporters might see them as a martyr, only fueling the movement.

No arrests happened at the meet-and-greet, but the YouTubers certainly made a scene. Eric Brandt, one of the auditors in attendance, told me that instead of getting Shang to admit to wrongdoing, I was there to get that womans reaction. In other words, he was trolling Shang out of deeply held political beliefs, and he did it all through a specific social media platform.

The politics I observed this past week, with both the mask debate and First Amendment auditing, were completely new to me. I saw libertarianism and constitutionalism in ways I wasnt previously exposed to. By the way, Im not commenting on the merit of those ideologies or whether I think theyre right or wrong. Thats not my place as a reporter. My whole point is that Im fascinated by it all. You cant make it up.

Im not surprised that new forms of political eclecticism are coming out of the woodwork in Brighton. To the south of the city is relatively liberal Denver and to the north is relatively conservative Weld County. Brighton is smack dab in the middle. What surprises me is how eclectic that eclecticism is. So, Brighton, thanks for keeping it spicy.

Cheers,

Liam

Read and share your thoughts on this story

Here is the original post:

Staff column: the Wide World of Politics, in Brighton - Brighton Standard-Blade

This Week in Technology + Press Freedom: July 19, 2020 – Reporters Committee for Freedom of the Press

Posted on by

On Thursday, the Technology and Press Freedom Projects Linda Moon will join Digital Strategist Tim Schwartz, author of A Public Service: Whistleblowing, Disclosure, and Anonymity, for a webinar dedicated to unpacking the rights of journalists and content producers during times of pandemic and protest. The webinar, hosted by Alley, a digital consulting firm, will explore strategies to help journalists safely document protests and police brutality and work with sources securely and remotely. Register for the webinarhere.

Also, the First Amendment Clinic at the University of Virginia School of Law is hiring alegal fellowfor the 2020-2021 and 2021-2022 academic years. The fellow will work with Reporters Committee attorneys Gabe Rottman and Jennifer Nelson, who administer the Clinic.

Heres what the staff of the Technology and Press Freedom Project at the Reporters Committee for Freedom of the Press is tracking this week.

A journalist has filed a lawsuit in federal court claiming police violated his federal and state constitutional rights, including the right to record police activity in public, after he was tackled and arrested while covering aJune 1 Black Lives Matter protestin Asbury Park, New Jersey.

According to a filingin the U.S. District Court for the District of New Jersey, Gustavo Martnez Contreras, a reporter for the Asbury Park Press, waslive-streaming the protestwhen he noticed police officers violently arrest two teenagers. The reporter was backing away from the scene, per instructions by the officers, but continued to record.

As documented in footage from the reporter and police body-worn cameras, officers then swore at Martnez Contreras, slapped his phone out of his hand, tackled him, and arrested him. The filing alleges that an officer later asked about the badge the journalist was wearing around his neck, which showed his press credentials, and that Martnez Contreras identified himself as a reporter on four other occasions.

The complaint, filed on July 13, notes that reporters rights must be as ingrained in policing as Miranda rights, and asks the court to order police not to interfere with First Amendment activities in the future. It also asks that the court require law enforcement to change their policies to prevent such interference, and for unspecified damages.

A press badge should not be a bullseye, the filing reads. Reporters should not be in danger of violence or arrest at the hands of the police seeking to silence their reports on public protests especially where those reports cover police violence against civilians protesting peacefully against police misconduct.

The same day the suit was filed, the Reporters Committeesent a letterto New Jersey officials protesting a local prosecutors reliance on Reporters Committee resources to clear the officers who arrested Martnez Contreras of wrongdoing.

Ininvestigative findingsreleased on June 8, the Monmouth County prosecutors office, which covers Asbury Park, claimed that the officers reasonably believed Martnez Contreras was a protester disobeying a lawful order. The report further claimed that the officers did not know Martnez Contreras was a reporter because he was allegedly not wearing bright clothing. The prosecutors office cited the Reporters Committeesguideandtip sheetfor journalists covering protests, which only provide practical safety advice, including that journalists should try not to wear clothing that matches what protesters are wearing.

The relevant legal standard, however, is whether officers reasonably should have known that Martnez Contreras was a reporter. The letter thus argues that the Reporters Committees resources do not support the prosecutors arguments, and asks that the findings be updated accordingly.

Abe Kenmore

NPR recentlyreportedthat foreign nationals working for Voice of America and other U.S. international broadcasters may not have their visas extended upon expiration, raisingfurther concernsover theeditorial independenceof VOA and its sister services. A decision not to renew these visas could impact dozens of employees, some of whom could face retaliation for their reporting if forced to return to their home countries.

The video app TikTok said it received500 demands for user datafrom governments in the first half of the year, up 67 percent from the second half of 2019. Most demands came from India which has since banned the app. The company reported that none of the demands were from China, the home of TikToks parent company. Reporters at theWashington Postrecently analyzed the data TikTok collects from users.

Verizon recentlylauncheda feature called Number Lock to provide added security to its customers. Number Lock allows users to prevent scammers from SIM swapping, or transferring a users number to another carrier in order to take control of bank, email, and social media accounts.

Defense Secretary Mark Esper has announcedan investigationwithin the Pentagon to weed out leakers, while White House Chief of Staff Mark Meadowsreportedly told some staffersthat he has fed information to suspected leakers to determine whether they then pass the information to the media. The inquiry comes in the wake of disclosures that led to reports of Russia offering bounties to Afghan militants for killing American troops.

On Thursday, Twitterreportedthat it was the target of a coordinated social engineering attack, which resulted in the accounts of hundreds of popular users posting spam-like messages about crypto currency. The company said the breach was conducted by unspecified individuals who targeted company employees with access to sensitive internal administrative systems.

Smart reads

Adeep diveby Voxs Recode explores the development and future of smartphone trackers, which can extract and aggregate data from a wide variety of apps.

Thisanalysisfrom the Columbia Journalism Review details the lengths media organizations have gone to in order to obtain and disseminate accurate data about COVID-19. Many news outlets have sued local officials for access to data, while others have created their own statistical tools to provide a complete picture of the pandemic in the absence of similar government resources.

Gif of the Week:Many quick hits this week remind us that cell phones can raise paw-sonal privacy issues.

Like what youve read?Sign up to get This Week in Technology + Press Freedom delivered straight to your inbox!

The Technology and Press Freedom Project at the Reporters Committee for Freedom of the Press uses integrated advocacy combining the law, policy analysis, and public education to defend and promote press rights on issues at the intersection of technology and press freedom, such as reporter-source confidentiality protections, electronic surveillance law and policy, and content regulation online and in other media. TPFP is directed by Reporters Committee Attorney Gabe Rottman. He works with Stanton Foundation National Security/Free Press Fellow Linda Moon, Legal Fellows Jordan Murov-Goodman and Lyndsey Wajert, Policy Interns Abe Kenmore and Joey Oteng, and Legal Intern Sasha Peters.

Visit link:

This Week in Technology + Press Freedom: July 19, 2020 - Reporters Committee for Freedom of the Press

Editorial A flushtrated community: Potsdam trampling on First Amendment rights of toilet artist – NNY360

Posted on by

In December 2018, the Potsdam Village Board of Trustees passed a junk storage law to address issues of unsightly items left out in public.

The new local law requires that items that could be categorized as junk cannot be in sight of people traveling the public highways, streets or thoroughfares of the village, according to the law, according to a story published Dec. 4, 2018, in the Watertown Daily Times. In a statement on the purpose of the measure, the village Board of Trustees wrote that having visible junk on front lawn is detrimental to the health, safety and general welfare of the community. The board also claimed that junk posed an attractive nuisance to children and may imperil their safety and that junk depreciates the value of property upon which junk is found as well as neighboring properties.

Trustees said this law was not an attempt to target parcels of land owned by Frederick J. Robar Sr.; they just believed some folks needed to tidy up around their homes. However, its difficult taking this claim seriously.

Since 2004, Mr. Robar has displayed what he calls toilet gardens. Its no secret that village officials dont hold their constituents artistic sentiments in high esteem, and the junk storage law was the latest mechanism implemented to compel him to clean up his sites.

Mr. Robar popped onto the villages radar in 2004 when he asked to get a zone change at his property on 82-84 Market St. so he could sell it to a buyer who would put in a Dunkin Donuts. When the village denied his request, he set up what is referred to now as a toilet garden. Since then, he and the village have butted heads twice inconclusively and unsuccessfully in the village court system, a June 30 article in the Times reported. In 2008, the village issued Mr. Robar an appearance ticket for a code violation. Mr. Robar argued that the toilet gardens are art and its his First Amendment right to have them. The case was dismissed because code enforcement officer John F. Hill failed to bring documents to the court. In 2010 the village tried again, but after the presiding judge resigned amid cocaine-use allegations, the case was dropped and the village decided not to pursue it.

Representatives of Clarkson University, the St. Lawrence Health System and Temple Beth El spoke out against Mr. Robars gardens. There likely arent too many people who enjoy viewing rows of toilets on adjacent property.

But Mr. Robars attorney, Mark Snider, said the law was created to punish his client after the fact. This would violate his constitutional rights, Mr. Snider said.

The village has so far been unable to force Mr. Robar to dismantle the gardens. This unconventional artist has maintained his landscape scenery through a court of law if not the court of public opinion. Officials are scheduled to discuss the matter Monday.

But for Potsdam to pursue this further may be flushing good tax dollars down the well, you know. This could end up being an expensive legal battle for the village with nothing in the end being changed.

The junk storage law does not apply to Mr. Robars properties. Hes not merely dumping unused bathroom fixtures outside his home because he doesnt know what else to do with them. He placed the toilets there as a personal expression, an act clearly protected by the First Amendment.

Village officials may not appreciate his artistic objective, but thats irrelevant. Its not their job to define what constitutes free speech the U.S. Constitution already does that.

Potsdam authorities are violating Mr. Robars rights by mandating he adhere to their idea of an acceptable visual presentation, and they need to stop their campaign against him.

Excerpt from:

Editorial A flushtrated community: Potsdam trampling on First Amendment rights of toilet artist - NNY360

New Developments in COVID-19 Litigation for New York City Landlords: Saving Grace or Hail Mary? – JD Supra

Posted on by

Since the COVID-19 pandemic began, real estate owners and tenants have faced unprecedented day-to-day operational challenges from the loss of business and income. Two new real estate lawsuits seek to address these issues.

The first is by a flagship retail lingerie store tenant doing business in the heart of Herald Square. The second is by property owners seeking a judicial declaration that new legislation enacted by the City Council on June 20 [Commercial Harassment Law (New York City Local Law 53 of 2020), Residential Harassment Law (New York City Local Law 56 of 2020), and the Guaranty Law (New York City Local Law 55 of 2020), collectively, the Harassment Law] is constitutionally defective and unenforceable. Victorias Secret Stores v. Herald Square Owner LLC, No. 651833/2020, (N.Y. Cty. Sup. Ct. 2020) and Melendez et al. v. City of New York et al., No. 20 Civ. 05301, (S.D.N.Y. 2020). The outcomes of these two cases may significantly impact the real estate industry and subsequent lawsuits, shifting the burdens of the pandemic from one segment of society to another.

On June 8, 2020, Victorias Secret sued its landlord, Herald Square Owner LLC, in New York State Supreme Court in connection with its lease of Two Herald Square claiming the store has been shuttered since mid-March and abandoned due to COVID-19. Victorias Secret seeks a declaration that its obligation to pay the $937,734.17 monthly rent is rescinded. The suit is predicated on three legal theories: frustration of purpose, impossibility of performance and reformation of the lease.

The Landlord recently moved to dismiss the Complaint. It first alleges that the parties negotiated and agreed to limit the abatement of rent (in a provision not found in the standard form commercial leases), whereby the Tenant agreed that if forced to close its store for 6 consecutive days solely because Landlord failed to perform any obligation, where such failure is expressly not caused by governmental preemption in connection with a national emergency or government order. Second, it argues that the contractual defenses of frustration of purpose and impossibility of performance are limited to cases where the event was not foreseen at the time the lease was made and the parties could have limited their exposure contractually, but did not do so. Third, the Landlord contends that the two types permissible reformation (scriveners error and mutual mistake) do not apply here, insofar as this particular lease generally allocated risk requiring the Tenant to pay rent for any forced store closing that is not due to an inexcusable failure solely by the Landlord, that the mistake was not about a fact existing at the time of lease execution and that such reformation is time-barred (6 years from the date of signing here, August 2001).

Victorias Secrets opposition to the Landlords motion is not due until July 29, 2020. Oral argument awaits.

On July 10, plaintiffs Marcia Melendez and Ling Yang both first-generation immigrants and landlords, sued in the Southern District of New York seeking to invalidate the Harassment Laws and Guarantee Law. They allege that the Harassment Laws violate the First Amendment, insofar as they prohibit otherwise lawful commercial speech (i.e., owners requesting the payment of rent and back rent). They contend that the Harassment Laws impermissibly restrict speech, and do not directly advance a government interest, nor are they tailored to meet that interest. Plaintiffs claim that the interest in helping small business owners is not advanced by the legislation, which actually hurts them as small business property owners insofar as it prevents them from making otherwise lawful requests for rent and back rent. The Plaintiffs further claim that the legislation is overly broad and vague by failing to define material terms. (Notably, the law itself does not define the term threatening or impacted by COVID-19.) The Harassment Laws impose civil penalties of $10,000 - $50,000. Parallel Fourteenth Amendment due process claims are also alleged under both federal and state law.

The Plaintiffs also bring another constitutional challenge against the Guarantee Law, claiming that it violates the Contracts Clause of the US Constitution that restricts passage of any law impairing the obligation of contracts (here, leases), by prohibiting landlords from enforcing personal (good guy) guarantees for unpaid rent owed by the tenant for the period March 7, 2020 to September 20, 2020. They argue that the law bars them forever from collecting unpaid rent, utilities, fees, building maintenance charges, or taxes owed by the tenant for defaults occurring during the same seven-month period by defining such collection efforts as harassment.

Finally, the Plaintiffs allege that the Harassment Laws directly conflict with existing New York State laws, particularly the State Legislatures conferring exclusive jurisdiction upon the Governor the authority to shape the contours of his Executive Orders on a state-wide basis to address the pandemic. The City has not yet responded to the lawsuit, which has been assigned to Judge Gregory H. Woods.

As we noted in our prior AF Alert, the force majeure defense in New York generally does not apply to the obligation to pay rent. This may be why Victorias Secret did not allege it (or possibly because as the landlord alleges, no such clause is in the lease). By the same token, New York law restricts the defenses of impossibility of performance and frustration of purpose to instances where the event triggering the lawsuit was unforeseen at the time the parties signed the lease. Victorias Secret like many other suits recently filed thus pits the classic battle between the express language of the lease against the tenants contention that COVID-19 was unforeseen. Parties would be advised to review their lease with a view toward negotiating appropriate language in connection with amendments, renewals, or rent adjustments. It would also be prudent to review insurance policies for coverage for specific causes of loss.

In regard to the Melendez case, the United States Supreme Courts decision in Central Hudson Gas and Electric Corp. v. Public Service Commission (1980) set up the first question that the district court likely will address: whether the speech at issue here (owners request for rent or back rent) is fraudulent or illegal. The Plaintiffs contend that there was negligible evidence demonstrating that landlords were using fraudulent means in requesting the rent. If the speech is found fraudulent or illegal, though, government regulation may be freely applied without First Amendment constraints. Proper consideration of whether the governments interest in protecting tenants was sufficiently tailored will also be at issue. The claims will also test whether the demand for rent during such a pandemic is fraught with overreaching or simply a contractual obligation that ought to be enforced. Stay tuned.

More:

New Developments in COVID-19 Litigation for New York City Landlords: Saving Grace or Hail Mary? - JD Supra

Allegations Swirl Around The Care Of Chimpanzees At Project Chimps, As reported In Animal Wildlife Watch – JD Supra

Posted on by

Care provided to chimpanzees at Project Chimps, a sanctuary for chimpanzees located in Georgia, has come under fire by [m]ore than 20 former staffers and volunteers, as reported by Rachel Fobar in Animal Wildlife Watch on July 8, 2020. Wildlife watch is an investigative reporting project between National Geographic Society and National Geographic Partners.

In 2015, NIH announced that it would retire the 50 NIH-owned chimpanzees that were then available for research, send them to sanctuaries and would also phase out its funding for the remaining research chimpanzees that it supports.

At the time, and since then, those involved with and responsible for the care of chimpanzees at universities and primate facilities expressed concern that the care these chimps would receive in sanctuaries would not meet the same standards of excellence in the facilities where staff had extensive training and expertise in their care, as previously reported.

As Dr. Cindy Buckmaster, Chair of Americans for Medical Progress described in 2016, some chimps who had been moved from their long-term care facilities to new sanctuaries suffered and some died after such a move. For example, Gimp, a 45 year old disabled chimp, tragically died after he was introduced and attacked by new cohorts at a sanctuary he had been relocated to. He had previously been housed at the retirement facility Chimpanzee Breeding and Rehabilitation Resource in Bastrop, Texaslater known as the Keeling Center and now officially coined the National Center for Chimpanzee Care (NCCC) for 35 of his 45 years. Gimp was described as a sweet, vulnerable chimp who would not hurt a sole.

If the reports about Project Chimps are true, then such unintended consequences resulting from the forced relocation of chimps to such sanctuaries may be repeated. Project Chimps, reportedly funded in part by the Humane Society of the United States, has been cited by USDA inspectors for (1) storing containers of materials toxic to the chimps including bleach and other disinfectants on an open shelf in the chimp housing areas (described as a repeat citation during a routine inspection on April 25, 2019; (2) on July 26, 2017 there were 2 non-compliant items listed on the inspection report, one for failure to maintain feed as required and without required labeling; and another because [t]he enrichment plan currently incorporated into the Chimpanzee Care Manual is not complete. It does not address the current social housing structure and the special considerations for chimps that may exhibit signs of psychological distress, juveniles and individually housed; and (3) on May 11, 2017 USDA was not able to inspect the facility because reportedly, [a] responsible adult was not available to accompany APHIS Officials during the inspection process at 11:50 am on that day.

Project Chimps filed a lawsuit against two former employees, Crystal Alba and Lindsay Vanderhoogt, first in state court on June 1, 2020 and later in federal court on July 13, 2020. In the latter lawsuit, which appears to be the active case, the following counts are alleged against one or both defendants: Breach of Contract, Defamation and Libel, Misappropriation under the Defend Secrets Act, Misappropriation under the Georgia Trade Secrets Act, Conversion, Tortious Interference with Business Relations, Violation of the Georgia Computer Systems Protection Act, Violation of the Stored Communication Act and Civil Conspiracy. Project Chimp alleges that the chimps medical records are amongst the documents it claims are its trade secrets.

No answer or substantive response has been filed by defendants in response to the Complaint. It remains to be seen whether whistleblower status and first amendment defenses will be raised. The parties have entered into settlement discussions, according to the Animal Wildlife Watch article.

[View source.]

Original post:

Allegations Swirl Around The Care Of Chimpanzees At Project Chimps, As reported In Animal Wildlife Watch - JD Supra

Trumps Legal Justification for the Abduction of Portland Protesters Is Absurd – Slate

Posted on by

President Donald Trump talks to reporters on Monday in the White House about expanding his secret police force.Doug Mills/Pool/Getty Images

Over the weekend, a group of Portland, Oregon, moms confronted federal officers who had fired tear gas at them and other peaceful protesters on Saturday outside of a federal courthouse. The escalation of the Portland protests came as unidentified federal officers in paramilitary uniforms were caught on tape abducting protesters and as President Donald Trump announced on Monday that he might send more federal law enforcement to cities run by liberal Democrats to replicate the Portland tactics against protesters, including efforts to grab them, a lot of people in jail. On Monday, it was reported that the Department of Homeland Security would be sending 150 federal agents to Chicago this week with an unspecified mandate. The apparent legal justification for the abduction of protesters is weak, and it should be vigorously challenged in the courts before Trump can export these tactics to other cities for use against citizens exercising their First Amendment rights.

Last week, people wearing combat fatigues were seen pulling apparently peaceful protesters off the streets of Portland, Oregon, and hustling them into unmarked vehicles. Their uniforms carried no identifying insignia, but they were clearly military uniforms.Based on the video evidence so far, the people being arrested were not engaged in crime. So we are faced with two questions.First, are these people military personnel, or are they police officers dressed up like soldiers? Second, do these people have the authority to sweep people off the street like this?

According to the Department of Homeland Security, the answer to the first question is that the force patrolling the streets of Portland consists of the FederalProtective Service, whose job it is to protect federal property. Personnel from other federal agenciesprincipally the Border Patrolhave also reportedly been deputized to assist in that mission.So these uniformed personnel are a militarized police force, which is always a dangerous thing. The answer to the second question is that, under the Fourth Amendment, this force does not have the authority to detain people like this. But government lawyers will rely on expansive theories of police power that cripple Fourth Amendment protection against unlawful seizures.This would not be the first time the federal government has tried this, though it appears to be one of the first targeting people exercising their First Amendment right to protest.

The Federal Protective Service has the authority to make arrests if the officer or agent has reasonable grounds to believe that the person to be arrested has committed or is committing a felony.If that doesnt sound right to you, it shouldnt. People cant be arrested unless the arresting officer has probable causenot merely reasonable groundsto believe a crime has been committed or is underway. Thats required by the Fourth Amendment to the Constitution, which presumptively prohibits seizures without probable cause.

The problem is that this presumption has been overwhelmed by constitutional semantics.When the Supreme Court decided that the stop-and-frisk tactic was permissible under the Fourth Amendment, it created a category of detention short of an arrest and authorized it where a police officer has reasonable suspicion of a crime, instead of probable cause.Over time, the court has set aside the probable cause requirement for every seizure that doesnt count as the direct enforcement of criminal law. When Border Patrol agents arrest someone for sneaking across the border, for example, they dont need probable cause.They dont even need a reasonable suspicion. They only need to detain the person in a reasonable mannerbecause patrolling the border is not criminal law enforcement.So both of the federal agencies involved here have been told they dont need probable cause to make arrests. And the legal theory behind these dangerous rules is the same: that these federal agents are engaged in protecting national security instead of criminal law enforcement.

But where the arrests in Portland are concerned, there are two reasons to believe that this wont stand up.First, there is the word felony in the law authorizing the Federal Protective Service to arrest without probable cause. An arrest for a felony is the direct enforcement of criminal law by definition. Nothing in the semantic campaign to drag as many seizures as possible into the national security category can change that definition. And an arrest for a felony requires probable cause.

Second, when government agents claim they have made a seizure for some purpose other than criminal law enforcementsuch as national securitythe Supreme Court has allowed the target of that seizure to argue that this purported purpose is an unlawful pretext. In the arrests captured on video so far, no imminent threat to federal property can be seen. More importantly, while Trump occasionally mentions protecting property, he has insisted again and again that city officials have failed to get control over antifa, anarchists, and agitators, and that he will do the job if they cant.If we take the president at his word, then the defense of property is a pretext, and the law allowing arrests on a reasonable basis for that purpose doesnt apply.

The uniforms these government agents are wearing are a deliberate attempt to evade accountability. But ultimately, it doesnt matter which federal agency is committing these unlawful seizures.Constitutional search and seizure questions turn on what government officials do, not which agency they work for.The important thing is that federal agents are lawless actors here. Their uniforms are nothing more or less than part of the national security pretext for their actions.

It is important to understand the full implications of the governments legal theory as it is playing out in Portland. It is the equivalent of declaring martial law for purposes of national security, based on the lie that military force is needed to keep the peace. Imposing martial law for national security is a tool of dictators, and Donald Trump has been a dictator in waiting for years. We can only hope that the wait isnt over.

Readers like you make our work possible. Help us continue to provide the reporting, commentary, and criticism you wont find anywhere else.

Read the rest here:

Trumps Legal Justification for the Abduction of Portland Protesters Is Absurd - Slate

Global Stem Cell Therapy Market Report Examines Analysis By Size, Share, Latest Trends, Future Growth, Top Key Players And Forecast To 2027 – Jewish…

Posted on by

The New Report Titled as Stem Cell Therapy Market published by Global Marketers, covers the market landscape and its evolution predictions during the forecast period. The report objectives to provide an overview of global Stem Cell Therapy Market with detailed market segmentation by solution, security type, application and geography. The Stem Cell Therapy Market is anticipated to eyewitness high growth during the forecast period. The report delivers key statistics on the market status of the leading market players and deals key trends and opportunities in the market.

Request For Free Sample Report: @ https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the Global Stem Cell Therapy Market are:

Celgene CorporationOsiris Therapeutics, Inc.Pharmicell Co., LtdMEDIPOST Co., Ltd.Promethera BiosciencesFibrocell Science, Inc.Holostem Terapie Avanzate S.r.l.Cytori TherapeuticsNuvasive, Inc.RTI Surgical, Inc.Anterogen Co., Ltd.RTI Surgical, Inc

The Stem Cell Therapy Market for the regions covers North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional breakdown has been done based on the current and forthcoming trends in the global Stem Cell Therapy Market along with the discrete application segment across all the projecting region.

Ask For Discount: https://www.reportspedia.com/discount_inquiry/discount/57925

The Type Coverage in the Market are:

Adult Stem CellsHuman EmbryonicInduced Pluripotent Stem CellsVery Small Embryonic Like Stem Cells

Market Segment by Applications, covers:

Regenerative MedicineDrug Discovery and Development

Some Major TOC Points:

Chapter 1. Stem Cell Therapy Market Report Overview

Chapter 2. Global Stem Cell Therapy Market Growth Trends

Chapter 3. Market Share by Key Players

Chapter 4. Stem Cell Therapy Market Breakdown Data by Type and Application

Chapter 5. Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Stem Cell Therapy Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Force

Continue for TOC

Do you want any other requirement or customize the report, Do Inquiry Here: https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#inquiry_before_buying

Key questions Answered in this Stem Cell Therapy Market Report:

What will be the Stem Cell Therapy Market growth rate and value in 2020?

What are the key market predictions?

What is the major factors of driving this sector?

What are the situations to market growth?

Major factors covered in the report:

Global Stem Cell Therapy Market summary

Economic Impact on the Industry

Stem Cell Therapy Market Competition in terms of Manufacturers

Stem Cell Therapy Market Analysis by Application

Marketing Strategy comprehension, Distributors and Traders

Study on Market Research Factors

Table of Content & Report Detail @ https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#table_of_contents

Read the original post:

Global Stem Cell Therapy Market Report Examines Analysis By Size, Share, Latest Trends, Future Growth, Top Key Players And Forecast To 2027 - Jewish...

Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease Summit – PRNewswire

Posted on by

LEXINGTON,Mass., July 21, 2020 /PRNewswire/ --Agenus Inc.(NASDAQ: AGEN), an immuno-oncology(I-O) companywith apipelineofimmunecheckpointantibodies, adoptive cell therapies and cancer vaccines,announcedtoday that Dr. Jennifer Buell, President and COO of Agenus, and Dr. Manuel Hidalgo, Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine/New York Presbyterian Hospital, will discuss AgenTus Therapeutics, Inc.'s (a subsidiary of Agenus) allogeneic iNKT cell therapy approach for infectious diseases at the B. Riley Virtual Infectious Disease Summit Therapeutics Day on a Panel entitled Pursuing Curative Cell Therapy Approaches.

Date: Tuesday, July 21, 2020

Time: 3:00 PM 4:00 PM ET

Title: Pursuing Curative Cell Therapy Approaches Cell Therapy has become a fast-changing field after becoming a powerful clinical therapy for late line cancer patients with the approval of the first generation CD19+ CAR T cell treatments (Yescarta and Kymriah). Participants in the panel include AgenTus Therapeutics, a biotech company and subsidiary of Agenus Inc. developing new cancer treatments, including AGENT-797, an early unmodified allogeneic iNKTcell therapy, Magenta Therapeutics, a cell therapy company developing novel cell therapies including MGTA-456, a stem -cell production therapy, and SQZ Biotechnologies Company, a biotech company developing oncology drugs including APC HPV, an autologous based therapy for several types of cancer.

Agenus Inc.Jennifer Buell, Ph.D. President and Chief Operating Officer Manuel Hidalgo, M.D. Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine/New York Presbyterian

Excision BioTherapeuticsDaniel Dornbusch - Chief Executive Officer

Pluristem Therapeutics (PSTI)Racheli Ofir Vice President of Research & IP

About AgenTus Therapeutics, Inc.AgenTus Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of breakthrough allogeneic iNKT cells in the unmodified and modified with engineered receptors, such as T cell receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge the human immune system cells to seek and destroy cancer. AgenTus also aims to advance adoptive cell therapy formats which would enable off-the-shelf living drugs. AgenTus has locations inLexington, MAandCambridge, UK. For more information, please visitwww.agentustherapeutics.com.

About AgenusAgenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer and infections. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit http://www.agenusbio.com and our Twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and twitter.

Contact:Agenus Inc.Jennifer Buell, PhD781-674-4420[emailprotected]

SOURCE Agenus Inc.

More here:

Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease Summit - PRNewswire

Stem Cell Therapy Market 2020 Recent Industry Developments and Growth Strategies Adopted by Top Key Players Worldwide and Assessment to 2026 – Cole of…

Posted on by

Lets begin with, why research is important for Stem Cell Therapy Market? It is always important because it gives direction to deal with a specific problem. Report Ocean has recently published a market research report on the Stem Cell Therapy Market which will provide you a leading direction of Stem Cell Therapy Market. This research report keenly focusses on development status and recent trends of the Stem Cell Therapy Market, along with competitive landscape, supply chain, market dynamics (opportunities, restraints, and drivers), government policies and opportunities.

The Stem Cell Therapy Market report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, and technological innovations.

COVID 19 Impact on Stem Cell Therapy Market

This research study also includes the analyses related to the impact of Covid-19 on the Stem Cell Therapy Market. The global impacts of the coronavirus disease 2019 (COVID-19) may significantly affect the growth of the Stem Cell Therapy Market in near future. As per the experts viewpoints, it affects the global economy in 3 major ways:

By directly affecting demand and production chain

By creating market disturbance and supply chain

By impacting the firms financially and influencing the financial markets

Request Free Sample Report athttps://www.reportocean.com/industry-verticals/sample-request?report_id=mai26603

Competitive Landscape:

Key players in the global Stem Cell Therapy market covered in Chapter 4:AnterogenCaladriusRTI SurgicalBIOTIMEOsiris TherapeuticsPharmicellAlloSourceMEDIPOSTJCR PharmaceuticalsBrainStorm Cell TherapeuticsHolostem Terapie AvanzateAdvanced Cell TechnologyNuVasive

In this chapter will provide you a complete description of competitors and their relative position in Stem Cell Therapy Market. We will provide you the information about major players, their products, prices, market share, current strategies and main strengths and weaknesses. In this competitive world, it is indispensable to understand who the rivals are and how they usually perform with the purpose of improving its own market position. Direct and indirect competitors should be identified and analyzed. This valuable information will support decision makers when defining and evaluating company strategies.

Market Segmentation:

For a business to grow, you always need to look at the specific group of consumers. It also helps you to avoid the cost of advertising and distributing to a mass market. In this section, we mainly focused on subdivision of the Stem Cell Therapy Market into compatible subsections of customers where any subsection may be selected as a market target to be reached with a unique marketing mix

Geographically, the report includes the detailed research on market share, growth rate, consumption, production, revenue and forecast of the following regions:

United States

Central and South America (Brazil, Mexico, Colombia)

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Some of the Major Highlights of TOC covers:

Report Overview

Study Scope

Key Market Segments

Regulatory Scenario by Region/Country

Market Investment Scenario Strategic

Global Market Growth Trends

Industry Trends

SWOT Analysis

Porters Five Forces Analysis

Potential Market and Growth Potential Analysis

Industry News and Policies by Regions

Industry News

Industry Policies

Industry Trends Under COVID-19

Value Chain of Stem Cell Therapy Market

Value Chain Status

Stem Cell Therapy Market Manufacturing Cost Structure Analysis

Production Process Analysis

Manufacturing Cost Structure of Stem Cell Therapy Market

Labor Cost of Stem Cell Therapy Market

Labor Cost of Stem Cell Therapy Market Under COVID-19

Sales and Marketing Model Analysis

Downstream Major Customer Analysis (by Region)

Value Chain Status Under COVID-19

Stem Cell Therapy Market Production, Revenue (Value), Price Trend by Type

Production and Market Share by Type

Revenue and Market Share by Type

Price by Type

Stem Cell Therapy Market Production, Consumption, Export, Import by Region

Production, Consumption, Export, Import by Region

Production, Consumption, Export, Import by Country

Production, Revenue, Price and Gross Margin

Industrial Chain, Sourcing Strategy and Downstream Buyers

Stem Cell Therapy Market Industrial Chain Analysis

Raw Materials Sources of Stem Cell Therapy Market major Players in 2019

Downstream Buyers

Stem Cell Therapy Market Forecast

Stem Cell Therapy Market Sales, Revenue and Growth Rate

Stem Cell Therapy Market Production, Consumption, Export and Import Forecast by Region

Stem Cell Therapy Market Production, Revenue and Price Forecast by Type

Stem Cell Therapy Market Consumption Forecast by Application

Stem Cell Therapy Market Forecast Under COVID-19

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

For more information and discount on this report, ask your query at:https://www.reportocean.com/industry-verticals/sample-request?report_id=mai26603

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, and Asia.

Contact Us: +1 888 212 3539 (US) +91-9997112116 (Outside US)Contact Person: Matthew SEmail:[emailprotected]

More:

Stem Cell Therapy Market 2020 Recent Industry Developments and Growth Strategies Adopted by Top Key Players Worldwide and Assessment to 2026 - Cole of...

GMP Cell Banking Services Market: Subsequent demand for stem cell therapies would provide a major boost to the market – BioSpace

Posted on by

Global GMP Cell Banking Services Market: Overview

A burgeoning pharmaceutical industry hard-pressed to find treatments and cures for various chronic and other ailments has given rise to the concept of cell banking. With limited capacity to store cells required for research in the field of regenerative medicines, somatic cell therapy, gene therapy, and tissue-engineered products they are increasingly outsourcing it to other entities specializing in it.

Read Report Overview - http://www.transparencymarketresearch.com/gmp-cell-banking-services-market.html

GMP basically stands for Good Manufacturing Practice. A recent report on GMP cell banking services finds that the market is set to rise in the near term with the capacity constraints being faced by the pharmaceutical manufacturing companies and medical research institutes.

An upcoming report on the global GMP cell banking services market by Transparency Market Research attempts to examine in depth the factors molding it. It studies both the market specific factors and macro fundamentals stoking or hindering market growth. The report also segments the GMP cell banking services market based on different parameters such as applications and geography. It then deep dives into each sector to understand which ones hold out maximum promise. The report also tries to figure out the current and future size of the market with respect to revenue generation.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50559

Global GMP Cell Banking Services Market: Key Trends

A cell bank comprises of a storage facility for cells extracted from different body fluids and organ tissue so that they can be used in the future. Stored cells contain detailed characterization of the cell line thereby decreasing chances of cross contamination. And GMP cell banking services consists of outsourcing gathering, storing, characterization, and testing facilities of cell lines, tissues, and cells. The report predicts that the rising popularity and subsequent demand for stem cell therapies would provide a major boost to the global GMP cell banking services market.

As per the TMR report, the global GMP cell banking services market is also being boosted by the development of cutting-edge preservation technologies and surging research in cell line development. However, complexity of the entire procedure and inconsistent demand is dampening market growth to an extent.

Request for Analysis of COVID19 Impact on GMP Cell Banking Services Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=50559

Depending upon the cell type, the global GMP cell banking services market can be segmented into microbial, mammalian, yeast, insect, stem cell, and avian, among others. Among them, the segment of mammalian currently has a significant share in the market. It generates most of the revenue and would probably rise at a healthy clip in the years to come. Meanwhile, the microbial segment is predicted to emerge as the most attractive in the upcoming years.

Global GMP Cell Banking Services Market: Regional Outlook

The global GMP cell banking services market is spread across North America, Europe, Asia Pacific, and the Middle East and Africa. North America, among them, is considered one of the attractive GMP cell banking services market with the mammalian cell type segment generating most of the revenue. The segment has also been generating substantial revenue in the Asia Pacific GMO cell banking services market. In fact, the Asia Pacific market is seeing solid rise because of the shift of research and development activities in the region from North America and Europe.

Pre Book GMP Cell Banking Services Market Research - https://www.transparencymarketresearch.com/checkout.php?rep_id=50559&ltype=S

Global GMP Cell Banking Services Market: Competitive Dynamics

The global GMP cell banking services market is fragmented in nature. This is because of the presence of several companies offering a range of services in it. This also limits their global outreach and localizes competition. Some the key players among them profiled in the report include WuXi AppTec, Eurofins Scientific, Charles River Laboratories International, Inc., Lonza Group Ltd., and SGS Ltd.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Read the original here:

GMP Cell Banking Services Market: Subsequent demand for stem cell therapies would provide a major boost to the market - BioSpace

Notch Therapeutics Appoints David Main as President and Chief Executive Officer to Advance the Company’s Novel Gene-Edited, iPSC-Derived Immune Cell…

Posted on by

TORONTO, July 20, 2020 /PRNewswire/ --Notch Therapeutics Inc., a biotechnology company creating universally compatible, off-the-shelf T cell therapies for cancer and immune disorders from renewable stem cell sources, is pleased to announce the appointment of David Main as President and Chief Executive Officer.

Notch is applying its scalable Engineered Thymic Niche (ETN) technology platform to develop homogeneous and universally compatible, stem cell-derived T cell therapies. To date, Notch has assembled a world-class scientific team and built a fully integrated, tightly controlled platform for generating and editing immune cells from clonal stem cells to enable development of a broad range of T cell therapeutics. Notch has also entered into a partnership with Allogene Therapeutics (NASDAQ: ALLO) to apply Notch's proprietary ETN platform to develop CAR-targeted, induced pluripotent stem cell (iPSC)-derived, off-the-shelf T cell or natural killer (NK) cell therapies for hematologic cancer indications.

"We have a clear goal at Notch: To create universally compatible, safe, and effective immunotherapies with the capability to treat thousands of patients from a single manufacturing run," said David Main. "The company has an internationally recognized team, a groundbreaking technology positioned to redefine and expand the clinical and commercial potential of cell therapy, and has already attracted a leading corporate partner. This is an exciting time to join and lead the company, which is now strongly positioned to advance our own pipeline of products as we also pursue additional partnering opportunities."

"We have spent the past year building a leading company developing next-generation, off-the-shelf immunotherapies driven by outstanding science and focused execution," said Ulrik Nielsen, Ph.D., Chairman of Notch. "David provides Notch with a proven industry leader and strategic thinker who has extensive experience driving and financing biotech innovation from early-stage research through commercial readiness. We are excited to bring in such outstanding leadership that is ideally suited to lead the company as it continues to advance its new class of off-the-shelf T cell therapy products."

Mr. Main is a highly experienced biopharmaceutical executive who brings to Notch more than 30 years of industry leadership experience with a strong track record of value creation and company growth. Most recently, as co-founder, Chairman, and CEO of Aquinox Pharmaceuticals, Mr. Main oversaw the advancement of the company's lead product from target validation through Phase 3 clinical trials. He also led the transition of Aquinox from a private to a NASDAQ-listed public company with approximately $300 million raised in equity capital and then completed the successful merger of Aquinox with Neoleukin Therapeutics. Prior to his leadership of Aquinox, Mr. Main served as President and CEO of INEX Pharmaceuticals and as a Vice President of QLT.

About Notch Therapeutics (www.notchtx.com)Notch is an immune cell therapy company creating universally compatible, allogeneic (off-the-shelf) T cell therapies for the treatment of cancer and immune disorders. Notch's technology platform uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and has the potential to deliver safer, consistently manufactured and more cost-effective cell immunotherapies to patients. At the core of Notch's technology is the synthetic Engineered Thymic Niche (ETN) platform, which precisely controls the expansion and differentiation of stem cells in a process suitable for large-scale manufacturing, delivering fully defined, consistent, feeder-free and serum-free T cells that can be genetically tailored for any T cell-based immunotherapeutic application. This technology was invented in the laboratories of Juan-Carlos Ziga-Pflcker, Ph.D. at Sunnybrook Research Institute and Peter Zandstra, Ph.D., FRSC at the University of Toronto. Notch was founded by these two institutions, in conjunction with MaRS Innovation (now Toronto Innovation Acceleration Partners) and the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto.

Contact:Mary MoynihanM2Friend Biocommunications802-951-9600[emailprotected]

SOURCE Notch Therapeutics

Notch Therapeutics

Read more:

Notch Therapeutics Appoints David Main as President and Chief Executive Officer to Advance the Company's Novel Gene-Edited, iPSC-Derived Immune Cell...

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis & Technological Innovation – Jewish Life News

Posted on by

Data Bridge Market Research has recently published the Global research Report TitledAutologous Stem Cell and Non-Stem Cell Based Therapies Market. The study provides an overview of current statistics and future predictions of the Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market.The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data.

Order a Free Sample Copy of thisAutologous Stem Cell and Non-Stem Cell Based Therapies Market Report:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-market

The Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market research report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global Autologous Stem Cell and Non-Stem Cell Based Therapies market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market in each region. Various methodological tools are used to analyze the growth of the worldwide Autologous Stem Cell and Non-Stem Cell Based Therapies market.

List of Companies Profiled in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report are:

Takeda Pharmaceutical Company Limited, Cytori Therapeutics Inc., General Electric Spiegelberg GmbH & Co. KG ., Medtronic, Natus Medical Incorporated., Integra LifeSciences Corporation, RAUMEDIC AG, Abbott., Endotronix, Inc. among others.

Major Regions as Follows:

North America

Europe

Asia-Pacific

South America

Middle East and Africa

Key Pointers Covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market Industry Trendsand Forecast to 2026

A complete value chain of the global Autologous Stem Cell and Non-Stem Cell Based Therapies market is presented in the research report. It is associated with the review of the downstream and upstream components of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market. The market is spliton the basis of the categories of products and clientapplication segments. The market analysis demonstrates the expansion of each segment of the global Autologous Stem Cell and Non-Stem Cell Based Therapies market. The research report assists the user in taking a decisive step on the way tobe a milestone ingrowingandexpandingtheirorganizationsinside theworldwideAutologous Stem Cell and Non-Stem Cell Based Therapies market.

How Does This Market Insights Help?

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart):https://www.databridgemarketresearch.com/toc/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-market

The report highlights current and future market trends and carries out an analysis of the effect of buyers, substitutes, new entrants, competitors, and suppliers on the market. The key topics that have been explained in this Autologous Stem Cell and Non-Stem Cell Based Therapies market report include market definition, market segmentation, key developments, competitive analysis and research methodology.

Why choose us:

TABLE OF CONTENTS

Part 01:Executive Summary

Part 02:Scope of the Report

Part 03:Research Methodology

Part 04:Market Landscape

Part 05:Pipeline Analysis

Part 06:Market Sizing

Market Definition

Market Sizing

Market Size And Forecast

Part 07:Five Forces Analysis

Bargaining Power Of Buyers

Bargaining Power Of Suppliers

Threat Of New Entrants

Threat Of Substitutes

Threat Of Rivalry

Market Condition

Part 08:Market Segmentation

Segmentation

Comparison

Market Opportunity

Part 09:Customer Landscape

Part 10:Regional Landscape

Part 11:Decision Framework

Part 12:Drivers and Challenges

Part 13:Market Trends

Part 14:Vendor Landscape

Part 15:Vendor Analysis

Vendors Covered

Vendor Classification

Market Positioning Of Vendors

Part 16:Appendix

In conclusion, the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report Give information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability inspection and venture return investigation.

To Get the Short-Term and Long-Term Impact of COVID-19 on this Market:https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-market

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Customization of the Report:

Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Contact:

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

[emailprotected]

Go here to see the original:

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis & Technological Innovation - Jewish Life News

Current Trend: Global Covid-19 impact on Cancer Stem Cell Therapy Market 2020 Size, Growth Opportunities, Research Analysis and Forecast to 2025 |…

Posted on by

Trending Cancer Stem Cell Therapy Market 2020: COVID-19 Outbreak Impact Analysis

Chicago, United States ,The report entitled Global Cancer Stem Cell Therapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 released byReport Hive Researchcomprises an assessment of the market which provides the real-time market scenario and its projections during 2020 to 2025 time-period. The report offers an understanding of the demographic changes that took place in recent years. The report presents an analysis of market size, share, growth, trends, statistical and comprehensive facts of the global Cancer Stem Cell Therapy market. This research study presents informative information and in-depth evaluation of the market and its segments based totally on technology, geography, region, and applications.

The report highlights several significant features of the global Cancer Stem Cell Therapy market encompassing competitive landscape, segmentation analysis, and industry environment. It shows the scope of the market and a brief overview of the definition and description of the product or service. The potential factors that can bring the market to the upward direction have been mentioned in the report. With this report, companies, as well as individuals interested in this report, will get proven valuable guidelines and direction so that they consolidate their position in the market.The report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the Cancer Stem Cell Therapyindustry. Growth of the overall Cancer Stem Cell Therapymarket has also been forecasted for the period 2020-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

>>>>To know How COVID-19 Pandemic Will Impact This Cancer Stem Cell Therapy Market| Download PDF Sample copy of the Report

>>>>The study encompasses profiles of major companies operating in the global Cancer Stem Cell Therapy Market. Key players profiled in the report include: AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics, Silicon Biosystems

Drivers And Risks:The report covers the basic dynamics of the global Cancer Stem Cell Therapy market. It scrutinizes several data and figures, and numerous volume trends. A number of potential growth factors, risks, restraints, challenges, market developments, opportunities, strengths, and weaknesses have been highlighted. Another factor affecting market growth has also been included in the report.

Analysis of Global Cancer Stem Cell Therapy Market By Type: Autologous Stem Cell TransplantsAllogeneic Stem Cell TransplantsSyngeneic Stem Cell TransplantsOthers

Analysis of Global Cancer Stem Cell Therapy Market By Application: HospitalClinicMedical Research InstitutionOthers

Regional Analysis:The report comprises of regional development status, covering all the major regions of the world. This regional status shows the size (in terms of value and volume), and price data for the global Cancer Stem Cell Therapy market. The development of the industry is assessed with information on the current status of the industry in various regions. Data type assessed concerning various regions includes capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export, etc.

Regional coverage:North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Some Main Reasons For Purchasing This Report:

Readers of this report will receive in-depth knowledge about the market.

Updated statistics offered on the global Cancer Stem Cell Therapy market report.

This report provides an insight into the market that will help you boost your companys business and sales activities.

It will help you to find prospective partners and suppliers.

It will assist and strengthen your companys decision-making processes.

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Cancer Stem Cell Therapy market.

Chapter 2: Evaluating the leading manufacturers of the global Cancer Stem Cell Therapy market which consists of its revenue, sales, and price of the products.

Chapter 3: the competitive nature among key manufacturers, with market share, revenue, and sales.

Chapter 4: Presenting global Cancer Stem Cell Therapy market by regions, market share and revenue and sales for the projected period.

Chapters 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

>>>>Get Full Customize report @ https://www.reporthive.com/request_customization/2360734

In this report, Leading players of the global Cancer Stem Cell Therapy Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Cancer Stem Cell Therapy Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Cancer Stem Cell Therapy Market. It also provides useful recommendations for new as well as established players of the global Cancer Stem Cell Therapy Market.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2360734

Why Go For Report Hive Research?

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: : https://www.reporthive.comEmail: [emailprotected]Phone:+1 312-604-7084

Read more:

Current Trend: Global Covid-19 impact on Cancer Stem Cell Therapy Market 2020 Size, Growth Opportunities, Research Analysis and Forecast to 2025 |...

New Research on Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020-2026 Industry Size, Share, Types, Regional Analysis, Manufacturers…

Posted on by

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2020 to 2026. Increasing prevalence of chronic diseases and adaptation of advanced technology are driving the market growth. However high cost of the therapy might restraint the market growth

For Sample Copy of this Report @ https://www.orianresearch.com/request-sample/1131253

What You Can Expect From Our Report:

Autologous Stem Cell and Non-Stem Cell Based Therapies Industry report offers a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures. On the basis of product, this report displays the cost structure, sales revenue, sales volume, gross margin, market share and growth rate.

Report Covers Market Segment by Manufacturers:

Report Covers Market Segment by Types:

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Industry 2020 Market Research Report is spread across 121 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Order Copy of this Report 2020 @ https://www.orianresearch.com/checkout/1131253

Report Covers Market Segment by Applications:

Key Benefits of the Report:

Target Audience:

Inquire more about Autologous Stem Cell and Non-Stem Cell Based Therapies Market report @ https://www.orianresearch.com/enquiry-before-buying/1131253

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics, capacity Types, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the

Key Industry Participants (KIPs) which typically include:

Table of Content

1 Executive Summary

2 Methodology And Market Scope

3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Industry Outlook

4 Autologous Stem Cell and Non-Stem Cell Based Therapies Market By End User

5 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Type

6 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Regional Outlook

7 Competitive Landscape

End of the report

Disclaimer

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Email: [emailprotected]

More here:

New Research on Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020-2026 Industry Size, Share, Types, Regional Analysis, Manufacturers...

NK Cell Therapy and Stem Cell Therapy Market 2020-26, Research Report Covers Updated Data Considering Impact of Covid-19 on Share, Size and Future…

Posted on by

NK Cell Therapy and Stem Cell Therapy Market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NK Cell Therapy and Stem Cell Therapy Market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Report Overview: This report covers an analysis of the global NK Cell Therapy and Stem Cell Therapy Market for the forecast period 2020-2026. It unravels that the market is set to register steady growth rate in the coming years. The valuation of the global market is covered for facilitating a comparative study of the past and future data. It also offers a detailed segmental assessment of the market based on different parameters.

Leading Key Players:Chipscreen BiosciencesInnate Pharma SAOsiris TherapeuticsChiesi PharmaceuticalsMolmedJCR PharmaceuticalAltor BioScience CorporationAffimed NVTakeda PharmaceuticalPharmicellMedi-postNuVasiveAnterogen

This analysis includes a detailed share analysis of the key players. It also unveils the growth trajectories of the NK Cell Therapy and Stem Cell Therapy Market participants along with their current statuses and key developments. The growth strategies employed by these players are also assessed in the report and are prognosticated to facilitate study of the competitive landscape of the global Artificial Heart Valve Market.

Get Free Sample [emailprotected] https://www.algororeports.com/sample-request/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=3wnews&utm_medium=53

Drivers and Restraints: The factors that are supposed to lead the expansion of the global market are highlighted in the assessment. The market factors are assessed and analyzed to understand their impact on the growth curve. Similarly, the factors that are presumed to restrain the growth of the market are also studied in the report.

Regional Analysis: The regions covered for the evaluation of the global NK Cell Therapy and Stem Cell Therapy Market are

North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

The analysis of these regional segment is followed by a country-level analysis of each for every region. A comparative study of the segments is offered with the inclusion of valuation for every segment on both country and regional level.

Method of Research: The assessment leverages advanced and robust methodologies to provide fact-based actionable insight into the market. Key market divergences are analyzed in the report for deriving accurate information regarding the growth trajectory of the market. These market divergences identified in the research process are current status of the market, ongoing industry trends, past data, latest developments, etc. Cutting-edge data analytical tools are employed for the filtration, validation, and authentication of data collected from primary and secondary research sources. The inputs are collected from credible sources, including but not limited to, paid database services, interviews with stakeholders across the value chain (MDs, CEOs, VPs,etc.), SEC filings, surveys, and whitepaper references among others. Zero deviation from facts is ensured with the utilization of a multi-layer verification process. It also assures adherence to the highest standards of data mapping and value extrapolation. Top-down and bottom-up approaches are executed to authenticate the accuracy of the quantitative data provided in the report.

CONTENTS

ENQUIREY TO BUY REPORT@ https://www.algororeports.com/enquiry/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=3wnews&utm_medium=53

About Us:

AlgoroReportsis one of the most significant database of online market researches and intelligence reports and services. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends. AlgoroReports Consists of a highly motivated team of young and experienced individual focused on providing clients expert information they need.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

Website: https://www.algororeports.com/

Ph: +1-352-353-0818 (US)

See the original post:

NK Cell Therapy and Stem Cell Therapy Market 2020-26, Research Report Covers Updated Data Considering Impact of Covid-19 on Share, Size and Future...